Document Detail

Failure of the Amplatzer ductal occluder II: kinking of the aortic retention disk at 24 hours.
MedLine Citation:
PMID:  20310021     Owner:  NLM     Status:  MEDLINE    
Since March 2008, the new Amplatzer duct occluder II (ADO II) has been used clinically for PDA closure in Europe. We report an interesting case of a 2(1/2)-year-old girl with a 3-mm conical shape PDA (type A PDA) who underwent uneventful implantation of 3/4 ADO II with complete closure by angiography and echocardiographic control at the end of the procedure. To our surprise, echocardiography 24 hr later revealed a moderate secondary shunt due to kinking of the aortic retention disk of the device with the central waist and the pulmonary retention disk still in correct position. The persistent shunt was closed 1 year later in the cath lab with a 9/6 Nit-Occlud device. To our knowledge, this is the first reported late complication directly related to the device.
Carsten Beck; Kai Thorsten Laser; Nikolaus A Haas
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions     Volume:  75     ISSN:  1522-726X     ISO Abbreviation:  Catheter Cardiovasc Interv     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-06-02     Completed Date:  2010-09-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100884139     Medline TA:  Catheter Cardiovasc Interv     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1100-3     Citation Subset:  IM    
Department for Congenital Heart Defects, Ruhr University Bochum, Bad Oeynhausen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Child, Preschool
Ductus Arteriosus, Patent / physiopathology,  radiography,  therapy*,  ultrasonography
Echocardiography, Doppler, Color
Heart Catheterization / adverse effects,  instrumentation*
Prosthesis Design
Prosthesis Failure*
Septal Occluder Device*
Time Factors
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious...
Next Document:  Stabilization of lysozyme by benzyl alcohol: surface tension and thermodynamic parameters.